glp 1 for addiction GLP-1 Weight-Loss Drugs Could Address a Range of Addictions GLP-1 medications are getting attention

Description

Appropriate use: During significant shortages or when branded medications are unattainable When a patient has a documented allergy or intolerance to an inactive ingredient in the FDA-approved product When a clinically justified dose or formulation is not commercially available for example, micro-dosing or alternative administration When a patient faces financial barriers and no affordable FDA-approved options are available, with documented clinical oversight and informed consent Inappropriate use: Simply for convenience or general cost-cutting without exploring other available, safer options For widespread, elective use without individualized clinical justification When used as a first-line alternative in place of available FDA-approved medications Decision-making checklist for employers: Confirm PCAB or equivalent pharmacy accreditation Require third-party testing for purity, potency, and sterility Clarify 503A vs

Here's a quick breakdown: If you're on Medicaid/Medi-Cal in California: Coverage for GLP-1 weight loss medications is no longer available as of January 2026

Please note that some features of our mobile applications and/or Services may not be usable or available to you if you do not grant us such permission